Commission Regulation (EEC) No 2959/93 of 27 October 1993 amending Regulation (EEC) No 3769/92 implementing and amending Council Regulation (EEC) No 3677/90 laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substances

COMMISSION REGULATION (EEC) No 2959/93 of 27 October 1993 amending Regulation (EEC) No 3769/92 implementing and amending Council Regulation (EEC) No 3677/90 laying down measures to be taken to discourage the diversion of certain substances to the  illicit manufacture of narcotic drugs and psychotropic substances
THE COMMISSION OF THE EUROPEAN COMMUNITIES
,
Having regard to the Treaty establishing the European Economic Community,
Having regard to Council Regulation (EEC) No 3677/90 of 13 December 1990 laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substances (1), as amended by  Commission Regulation (EEC) No 900/92 (2), and in particular Article 10 (3) thereof,
Having regard to Commission Regulation (EEC) No 3769/92 (3) implementing and amending Council Regulation (EEC) No 3677/90, hereinafter referred to as 'the basic Regulation',
Whereas certain substances used for the illicit manufacture of narcotic drugs and psychotropic substances listed in categories 2 and 3 are subject to targeted controls and are subject to an export authorization requirement when they are exported to  countries classed as sensitive;
Whereas the lists of sensitive destinations for the substances in question are contained in Annexes II and III to Regulation (EEC) No 3769/92;
Whereas the identification of sensitive destinations has to take place on the basis that a country is concerned, either by the illicit manufacture of narcotic drugs and psychotropic substances or by other relevant factors such as geographical proximity  to a country in which such drugs or substances are produced;
Whereas in identifying sensitive destinations, the Commission, acting in agreement with the Member States' delegations, has preferred to establish contacts with each individual country concerned;
Whereas such approach was adopted in respect of a number of countries with a view to including them in the list of sensitive destinations and an initial list of countries was drawn up and annexed to Regulation (EEC) No 3769/92;
Whereas new concrete results having been reached through these contacts since the adoption of Regulation (EEC) No 3769/92, the list must be updated to include these new countries and, for reasons of transparency, the Annexes II and III to this  Regulation need to be replaced;
Whereas the measures provided for in this Regulation are in accordance with the opinion of the Drugs Precursors Committee,